Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Life sciences
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
About
Home
NICE guidance
Published
Published: Guidance, quality standards and advice
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic selection
Filter (12 applied)
Skip to results
Keyword or reference number
Keyword or reference number
Apply filter
Last updated date
Last updated date
From date
To date
Apply date filters
Area of interest
Area of interest
Antimicrobial prescribing (18)
COVID-19 (2)
Type
(
2 selected
)
Type
Guidance (661)
Quality standard (0)
Guidance programme
(
9 selected
)
Guidance programme
Antimicrobial prescribing guidelines (18)
Cancer service guidelines (0)
Clinical guidelines (136)
COVID-19 rapid guidelines (2)
Diagnostics guidance (25)
Health technology evaluations (17)
Highly specialised technologies guidance (22)
Interventional procedures guidance (172)
Medical technologies guidance (55)
Medicines practice guidelines (0)
NICE guidelines (177)
Public health guidelines (14)
Safe staffing guidelines (0)
Social care guidelines (21)
Technology appraisal guidance (418)
Apply filters
Showing 1 to 25 of 661
Sort by
Date
Title
Apply sorting
Last updated date between: 1/4/2018 and 28/3/2024
Remove Last updated date between: 1/4/2018 and 28/3/2024 filter
Type: Guidance
Remove Type: Guidance filter
Type: Quality standard
Remove Type: Quality standard filter
Guidance programme: Technology appraisal guidance
Remove Guidance programme: Technology appraisal guidance filter
Guidance programme: Interventional procedures guidance
Remove Guidance programme: Interventional procedures guidance filter
Guidance programme: Highly specialised technologies guidance
Remove Guidance programme: Highly specialised technologies guidance filter
Guidance programme: Social care guidelines
Remove Guidance programme: Social care guidelines filter
Guidance programme: Antimicrobial prescribing guidelines
Remove Guidance programme: Antimicrobial prescribing guidelines filter
Guidance programme: Public health guidelines
Remove Guidance programme: Public health guidelines filter
Guidance programme: Cancer service guidelines
Remove Guidance programme: Cancer service guidelines filter
Guidance programme: Medicines practice guidelines
Remove Guidance programme: Medicines practice guidelines filter
Guidance programme: Safe staffing guidelines
Remove Guidance programme: Safe staffing guidelines filter
Published guidance, NICE advice and quality standards
Title
Reference number
Published
Last updated
Sebelipase alfa for treating lysosomal acid lipase deficiency that is not Wolman disease (terminated appraisal)
TA961
28 March 2024
28 March 2024
Olaparib for maintenance treatment of BRCA mutation-positive advanced ovarian, fallopian tube or peritoneal cancer after response to first-line platinum-based chemotherapy
TA962
28 March 2024
28 March 2024
Human alpha1-proteinase inhibitor for treating emphysema (terminated appraisal)
TA965
28 March 2024
28 March 2024
Ritlecitinib for treating severe alopecia areata in people 12 years and over
TA958
27 March 2024
27 March 2024
Daratumumab in combination for treating newly diagnosed systemic amyloid light-chain amyloidosis
TA959
27 March 2024
27 March 2024
Satralizumab for preventing relapses in neuromyelitis optica spectrum disorders (terminated appraisal)
TA960
27 March 2024
27 March 2024
Momelotinib for treating myelofibrosis-related splenomegaly or symptoms
TA957
20 March 2024
20 March 2024
Nirmatrelvir plus ritonavir, sotrovimab and tocilizumab for treating COVID-19
TA878
29 March 2023
13 March 2024
Fluocinolone acetonide intravitreal implant for treating chronic diabetic macular oedema
TA953
13 March 2024
13 March 2024
Dupilumab for treating moderate to severe prurigo nodularis
TA955
13 March 2024
13 March 2024
Etrasimod for treating moderately to severely active ulcerative colitis in people aged 16 and over
TA956
11 March 2024
11 March 2024
Epcoritamab for treating relapsed or refractory diffuse large B-cell lymphoma after 2 or more systemic treatments
TA954
6 March 2024
6 March 2024
Endoscopic sleeve gastroplasty for obesity
IPG783
22 February 2024
22 February 2024
Talazoparib for treating HER2-negative advanced breast cancer with germline BRCA mutations
TA952
21 February 2024
21 February 2024
Belumosudil for treating chronic graft-versus-host disease after 2 or more systemic treatments in people 12 years and over
TA949
7 February 2024
7 February 2024
Nivolumab–relatlimab for untreated unresectable or metastatic melanoma in people 12 years and over
TA950
7 February 2024
7 February 2024
Olaparib with abiraterone for untreated hormone-relapsed metastatic prostate cancer
TA951
7 February 2024
7 February 2024
Loncastuximab tesirine for treating relapsed or refractory diffuse large B-cell lymphoma and high-grade B-cell lymphoma after 2 or more systemic treatments
TA947
31 January 2024
31 January 2024
Ivosidenib for treating advanced cholangiocarcinoma with an IDH1 R132 mutation after 1 or more systemic treatments
TA948
31 January 2024
31 January 2024
Treosulfan with fludarabine before allogeneic stem cell transplant for people aged 1 month to 17 years with non-malignant diseases (terminated appraisal)
TA945
30 January 2024
30 January 2024
Pharyngeal electrical stimulation for neurogenic dysphagia
IPG781
23 January 2024
23 January 2024
Temperature control to improve neurological outcomes after cardiac arrest
IPG782
23 January 2024
23 January 2024
Olaparib with bevacizumab for maintenance treatment of advanced high-grade epithelial ovarian, fallopian tube or primary peritoneal cancer
TA946
17 January 2024
17 January 2024
Durvalumab with gemcitabine and cisplatin for treating unresectable or advanced biliary tract cancer
TA944
10 January 2024
10 January 2024
Sebelipase alfa for treating Wolman disease
HST30
10 January 2024
10 January 2024
Current page
1
2
3
…
27
Page
1
of
27
Next page
Results per page
10
25
50
All
Back to top